Hologic CEO Steve MacMillan to Exit as Blackstone/TPG Takeover Nears Completion
Event summary
- Steve MacMillan, Hologic's CEO since 2013, to retire upon completion of $16.4B Blackstone/TPG takeover on April 7, 2026.
- MacMillan oversaw 65% revenue growth, 184% non-GAAP EPS increase, and 241% share price surge during his tenure.
- Hologic's workforce expanded by over 1,500 employees under MacMillan's leadership.
- Next CEO to be announced upon transaction close.
The big picture
Hologic's transition to private ownership marks a significant shift in the medical technology landscape, particularly in women's health. The $16.4B deal reflects growing private equity interest in specialized healthcare sectors. MacMillan's departure follows a successful turnaround and growth period, raising questions about how new leadership will navigate post-acquisition challenges.
What we're watching
- Leadership Continuity
- How the new CEO will maintain Hologic's growth trajectory post-transaction.
- Private Equity Strategy
- Whether Blackstone and TPG can unlock additional value in Hologic's women's health portfolio.
- Operational Integration
- The pace at which the private equity owners implement strategic changes post-acquisition.
Related topics